Thursday, Apr 30th
Last update07:41:37 AM GMT
The Food and Drug Administration said Thursday that it will sharply limit access to the anti- diabetes drug Avandia because of concerns about an increased cardiovascular risk associated with the drug.
Patients who are now taking the drug will have to sign an informed consent statement acknowledging that they understand all the risks before they will be allowed to continue refilling prescriptions.
 A former senior adviser at the National Institute of Allergy and Infectious Diseases is facing charges... |
 When Bug got home from school one winter afternoon in late 2024, his mother was on... | ||
 A Pennsylvania court on Monday said that the state’s constitution guarantees a right to abortion while... |
 Donald Trump has selected Erica Schwartz to lead the Centers for Disease Control and Prevention (CDC),... |
